← All organizations
Highest phase reached
Phase 3
First clinical trial
Aug 17, 2018First marketed drug
Dec 23, 2022First NDA
Dec 23, 2022Last known activity
Feb 29, 2024
Timeline
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Marketed drugs (1)
Recent trials (5)
- NCT06271408Lead sponsorPhase 1Feb 29, 2024
- NCT03418090Lead sponsorPhase 3Aug 17, 2018
- NCT03417687Lead sponsorPhase 3Aug 17, 2018
- NCT03418090Study directorPhase 3Aug 17, 2018
- NCT03417687Study directorPhase 3Aug 17, 2018
Details
- Founded
- Durham, NC, US Jun 1, 2011
- First NDA
- Dec 23, 2022
- Last known activity
- Feb 29, 2024